Nagano, H.;                     Ohyama, S.;                     Sato, A.;                     Igarashi, J.;                     Yamamoto, T.;                     Kobayashi, M.    
        Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer. Curr. Oncol. 2025, 32, 506.
    https://doi.org/10.3390/curroncol32090506
    AMA Style
    
                                Nagano H,                                 Ohyama S,                                 Sato A,                                 Igarashi J,                                 Yamamoto T,                                 Kobayashi M.        
                Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer. Current Oncology. 2025; 32(9):506.
        https://doi.org/10.3390/curroncol32090506
    
    Chicago/Turabian Style
    
                                Nagano, Hideki,                                 Shigekazu Ohyama,                                 Atsushi Sato,                                 Jun Igarashi,                                 Tomoko Yamamoto,                                 and Mikiko Kobayashi.        
                2025. "Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer" Current Oncology 32, no. 9: 506.
        https://doi.org/10.3390/curroncol32090506
    
    APA Style
    
                                Nagano, H.,                                 Ohyama, S.,                                 Sato, A.,                                 Igarashi, J.,                                 Yamamoto, T.,                                 & Kobayashi, M.        
        
        (2025). Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer. Current Oncology, 32(9), 506.
        https://doi.org/10.3390/curroncol32090506